What You Should Know:
- Revalia Bio Inc., a new pre-clinical research company secures $14.5M in seed funding round to support the launch of its "Human Data Trials".
- The funding was co-led by America's Frontier Fund and Sierra Ventures, with participation from Roger Ferguson, former Vice Chair of the U.S. Federal Reserve, and other existing investors. This brings Revalia's total funding to $19.5M.
A New Paradigm for Pre-Clinical Research
The investment comes at a crucial time
Read More
HealthEdge and UST HealthProof Merge to Modernize Health Plans
What You Should Know:
- HealthEdge and UST HealthProof have announced the successful completion of their merger, following Bain Capital's acquisition of UST HealthProof from UST.
- The combined company will operate as HealthEdge, with its headquarters in Boston. With a reach that touches over 110 million lives in the U.S., HealthEdge is now positioned to empower health plans with modern, AI-enabled technology and services that can lower total costs and improve operational
Read More
MCG Health and Avo Launch AI Assistant to Reduce Hospital Length of Stay
What You Should Know:
- MCG Health, a part of the Hearst Health network, and Avo, a clinician-created AI platform, have launched a new AI assistant designed to tackle the challenge of hospital length of stay (LOS).
- The partnership integrates recovery milestones from MCG's proprietary guidelines directly into electronic health record (EHR) workflows using Avo's new assistant. This tool gives hospitalists and case managers a real-time picture of each patient’s readiness to go
Read More
HHS Announces Crackdown on Information Blocking to Empower Patients and Innovators
What You Should Know:
- The U.S. Department of Health and Human Services (HHS) has announced a new initiative to increase resources dedicated to curbing the practice of "information blocking".
- Secretary Robert F. Kennedy, Jr. has directed HHS to take active enforcement against healthcare entities that restrict patients’ access, exchange, and use of electronic health information.
Empowering Patients and Innovators
The announcement states Information blocking was not
Read More
Parasym Launches Nuropod, a Non-Invasive Vagus Nerve Stimulation Device
What You Should Know:
- Parasym has launched Nuropod, the first ear-based, clinically studied vagus nerve stimulation (VNS) device in the U.S. that does not require surgery.
- The wearable device is designed to reduce symptoms such as persistent fatigue, anxious states, and markers related to inflammation by activating the vagus nerve to restore the body’s "rest and digest" state. The device is backed by more than 50 completed clinical studies.
A Non-Surgical Alternative
Read More
Prominence Advisors Acquires Tegra Analytics to Unify Healthcare and Life Sciences Data
What You Should Know:
- Prominence Advisors, a leader in healthcare data enablement, has announced its acquisition of Tegra Analytics, a life sciences analytics consultancy. The acquisition extends Prominence's data enablement platform into the life sciences sector, strengthening its services across providers, payers, and life sciences organizations.
- The acquistion will bring together expertise from both healthcare and life sciences, along with industry-leading customer service.
Read More
Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys
What You Should Know:
- Today, Epic announced the launch of a new form of healthcare intelligence, named Comet, developed to help clinicians, health systems, and patients make more informed decisions.
- Built on Epic Cosmos, a secure data platform, Comet is designed to predict what is likely to happen next in a patient’s journey by estimating disease risk, length of stay, and treatment outcomes. The platform has learned from more than 100 billion patient medical events to
Read More
NewDays Secures $7M to Expand AI-Powered Cognitive Health Program to Texas
What You Should Know:
- NewDays, a company offering a science-backed cognitive health treatment program, has announced an oversubscribed $7M seed funding round from General Catalyst and Madrona.
- The company is also expanding its services to Texas, following a successful pilot phase in California, Washington, and Florida. The expansion aims to address the significant challenge of cognitive impairment in the U.S., where 1 in 3 people over the age of 65 have a serious cognitive
Read More
ArcaScience Raises $7M to Advance AI-Powered Drug Benefit-Risk Evaluation
What You Should Know:
- ArcaScience, a Paris, France-based AI Healthtech startup, has announced a $7M seed funding round led by The Moon Venture, with participation from Pléiade Venture, Plug&Play Ventures, Bpifrance, and AKKA Technologies. This marks the company's first institutional funding round, following a €1.3 million pre-seed raise.
- The new funds will be used to expand operations in the U.S. and U.K., launch the company’s first patient-facing solution, and strategically
Read More
WellSpan Health and General Catalyst Partner to Transform Healthcare Delivery
What You Should Know:
- WellSpan Health and General Catalyst’s Health Assurance Transformation Company (HATCo) have announced an expanded collaboration.
- The new initiative builds on a strategic partnership that began in 2023, with WellSpan Health becoming the first Transformation Partner to HATCo. The two organizations will work together to modernize and transform healthcare delivery through the development of new AI technologies.
Targeting Three Critical Areas of
Read More
